Why Quest Diagnostics Is Trading Higher Today

Quest Diagnostics DGX shares are trading higher on Monday after getting an upgrade.

Analysts at Citigroup upgraded the company's stock from Neutral to Buy and raised the price target from $113 to $130.

Quest Diagnostics is a clinical laboratory and operates in the U.S, U.K, Mexico and Brazil.

Quest Diagnostics shares are trading up 7.56% at $114.62 at time of publication. The stock has a 52-week high of $118.58 and a 52-week low of $73.02.